See more : Guolian Securities Co., Ltd. (1456.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Resonance Health Limited (RHT.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Resonance Health Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- RHÖN-KLINIKUM Aktiengesellschaft (RKAGY) Income Statement Analysis – Financial Results
- Hawaiian Electric Company, Inc. PFD SER I 5% (HAWLN) Income Statement Analysis – Financial Results
- Garware Marine Industries Limited (GARWAMAR.BO) Income Statement Analysis – Financial Results
- PT Jakarta Kyoei Steel Works, Tbk (JKSW.JK) Income Statement Analysis – Financial Results
- Charlotte’s Web Holdings, Inc. (CWEB.TO) Income Statement Analysis – Financial Results
Resonance Health Limited (RHT.AX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.resonancehealth.com
About Resonance Health Limited
Resonance Health Limited, a healthcare technology and services company, designs, develops, and manufactures software-as-medical devices in the Asia Pacific, North America, South America, Europe, the Middle East, and Africa. It offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-assisted device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also offers quantitative imaging measurements and CRO, such as quality-assured image analysis, imaging charter development, project and data management, issue resolution, site tracker and clinical trial progress report, and coordination of data flow services; biomarkers, blood, urine, and protein analytes, as well as RNA, DNA, and genotyping services; and protocol development, assessment of subject inclusion or exclusion, decisions on dose modifications, and evaluating the safety profile of a new therapy, as well as supporting primary and secondary end-points demonstrating drug efficacy services for multinational and multicenter clinical trials; and phantoms for the calibration of MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.59M | 4.40M | 3.83M | 3.78M | 3.67M | 3.62M | 2.90M | 2.49M | 2.55M | 2.44M | 2.28M | 1.53M | 1.56M | 1.75M | 1.84M | 2.26M | 1.72M | 1.87M | 316.07K | 121.57K | 3.30K | 19.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 8.59M | 4.40M | 3.83M | 3.78M | 3.67M | 3.62M | 2.90M | 2.49M | 2.55M | 2.44M | 2.28M | 1.53M | 1.56M | 1.75M | 1.84M | 2.26M | 1.72M | 1.87M | 316.07K | 121.57K | 3.30K | 19.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 835.82K | 708.25K | 716.23K | 393.93K | 152.28K | 63.18K | 123.02K | 164.47K | 111.16K | 68.67K | 70.87K | 56.21K | 80.41K | 140.63K | 111.36K | 152.89K | 179.89K | 83.30K | 303.53K | 409.22K | 473.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.55M | 3.14M | 2.50M | 2.00M | 3.57M | 1.67M | 1.78M | 1.56M | 1.47M | 1.35M | 1.32M | 1.38M | 1.44M | 1.33M | 1.27M | 979.93K | 1.04M | 1.23M | 1.58M | 1.56M | 869.50K | 403.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 904.64K | 817.67K | 1.02M | 241.05K | 236.46K | 266.31K | 583.61K | 629.53K | 781.54K | 371.73K | 173.23K | 218.64K | 198.95K | 349.38K | 334.07K | 159.76K | 25.39K | 28.70K | 269.32K | 75.15K | 98.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.16M | 3.95M | 3.52M | 2.25M | 3.81M | 1.94M | 2.37M | 2.19M | 2.26M | 1.72M | 1.50M | 1.60M | 1.64M | 1.68M | 1.60M | 1.14M | 1.06M | 1.26M | 1.85M | 1.63M | 968.30K | 403.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 352.36K | 1.37M | 951.25K | 888.55K | 756.76K | 18.99K | -24.59K | -39.18K | 295.93K | -173.45K | 302.64K | 185.15K | -36.86K | 60.05K | 6.51K | -18.20K | -95.19K | 233.07K | 111.77K | 628.04K | 0.00 | 1.61M | 320.86K | -18.66M | -3.96M | -2.54M | -828.45K | 10.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| Operating Expenses | 8.00M | 6.03M | 5.60M | 3.59M | 4.85M | 2.76M | 3.16M | 3.11M | 3.04M | 2.56M | 2.21M | 2.23M | 2.28M | 2.29M | 2.22M | 1.82M | 2.11M | 2.83M | 4.12M | 3.30M | 2.07M | 403.73K | 3.08M | 320.86K | -18.66M | -3.96M | -2.54M | -828.45K | 10.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| Cost & Expenses | 8.00M | 6.03M | 5.60M | 3.59M | 4.85M | 2.76M | 3.16M | 3.11M | 3.04M | 2.56M | 2.21M | 2.23M | 2.28M | 2.29M | 2.22M | 1.82M | 2.11M | 2.83M | 4.12M | 3.30M | 2.07M | 403.73K | 3.08M | 320.86K | -18.66M | -3.96M | -2.54M | -828.45K | 10.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| Interest Income | 137.83K | 39.90K | 3.32K | 37.48K | 41.31K | 37.23K | 15.22K | 27.86K | 48.94K | 65.52K | 24.47K | 35.91K | 98.27K | 78.14K | 92.05K | 125.26K | 147.03K | 136.55K | 69.18K | 49.85K | 45.84K | 19.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 3.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | 9.00K | 6.35K | 984.00 | 1.95K | 1.95K | 154.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 497.95K | 436.36K | 429.11K | 364.16K | 340.57K | 245.05K | 179.95K | 193.23K | 149.24K | 134.70K | 108.57K | 53.15K | 20.30K | 21.17K | 24.58K | 26.03K | 34.20K | 42.95K | 50.33K | 323.46K | 68.84K | 19.00K | 1.61M | 320.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -381.53K | -1.19M | -1.34M | 707.69K | -839.34K | 1.11M | -81.54K | -425.50K | -344.45K | 21.88K | 181.77K | -646.78K | -696.82K | -523.55K | -359.70K | 462.40K | -349.03K | -915.04K | -3.75M | -2.85M | -2.00M | -384.73K | -1.46M | -7.34M | -18.66M | -3.96M | -2.54M | -828.45K | 10.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| EBITDA Ratio | -4.44% | -26.27% | -35.09% | 14.62% | -22.88% | 30.68% | -2.78% | -17.25% | -13.52% | 0.90% | 7.96% | -42.34% | -44.74% | -29.99% | -19.57% | 20.47% | -20.27% | -48.96% | 2,858.11% | -2,347.72% | -60,523.45% | -2,024.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 593.95K | -1.59M | -1.77M | 188.19K | -1.18M | 867.09K | -261.49K | -622.00K | -493.69K | -112.82K | 73.20K | -699.94K | -717.11K | -544.72K | -384.29K | 436.36K | -383.23K | -957.98K | -3.80M | -3.18M | -2.07M | -403.73K | -3.08M | -320.86K | -18.66M | -3.96M | -2.54M | -828.45K | 10.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| Operating Income Ratio | 6.91% | -36.18% | -46.30% | 4.98% | -32.17% | 23.92% | -9.03% | -25.03% | -19.38% | -4.62% | 3.20% | -45.83% | -45.90% | -31.20% | -20.91% | 19.32% | -22.25% | -51.26% | -1,203.40% | -2,613.79% | -62,609.45% | -2,124.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.22M | -438.57K | -615.35K | -371.49K | 227.22K | 74.59K | 34.21K | 3.27K | 9.76K | -337.53K | -148.98K | 338.54K | 283.42K | 41.29K | 152.10K | 131.77K | 128.83K | 41.36K | -12.48M | 161.61K | 45.84K | 6.51M | 614.63K | -7.35M | -6.35K | -984.00 | -1.95K | -1.95K | -154.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -626.89K | -1.26M | -1.55M | 343.52K | -952.70K | 941.68K | -226.39K | -618.72K | -483.93K | 248.63K | -75.78K | -361.31K | -435.90K | -503.43K | -232.19K | 568.13K | -254.40K | -916.62K | -16.29M | -3.02M | -2.02M | 6.10M | -2.46M | -7.68M | -18.66M | -3.96M | -2.54M | -830.39K | -144.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| Income Before Tax Ratio | -7.30% | -28.70% | -40.53% | 9.09% | -25.97% | 25.98% | -7.82% | -24.89% | -18.99% | 10.18% | -3.32% | -23.66% | -27.90% | -28.84% | -12.63% | 25.15% | -14.77% | -49.05% | -5,153.36% | -2,480.85% | -61,220.52% | 32,117.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -796.19K | -483.70K | -409.75K | -242.33K | -237.62K | -328.56K | -451.01K | -314.51K | -99.56K | -214.60K | -3.37K | -188.65K | -167.29K | -186.60K | -129.85K | -48.92K | -213.01K | -191.30K | -227.38K | -3.02M | -2.02M | 6.10M | -2.46M | -7.68M | -18.66M | -3.96M | -2.54M | -830.39K | -144.00K | -405.00K | -258.00K | -186.00K | -260.00K | -221.00K | -180.00K |
| Net Income | 169.30K | -780.36K | -1.14M | 585.86K | -715.08K | 1.27M | 224.62K | -304.22K | -384.37K | 463.23K | -72.42K | -172.67K | -268.60K | -316.83K | -102.34K | 617.05K | -41.39K | -725.32K | -16.06M | 1.11M | 757.08K | 6.10M | -2.46M | 423.00K | 45.52K | 67.58K | -2.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 1.97% | -17.72% | -29.83% | 15.50% | -19.49% | 35.05% | 7.76% | -12.24% | -15.09% | 18.96% | -3.17% | -11.31% | -17.19% | -18.15% | -5.57% | 27.31% | -2.40% | -38.81% | -5,081.42% | 912.75% | 22,941.94% | 32,117.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.07 | -0.02 | -0.02 | 0.12 | -0.50 | 0.09 | 0.02 | 0.02 | -1.32 | -0.69 | -0.17 | -0.46 | -0.30 | -0.22 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.07 | -0.02 | -0.02 | 0.12 | -0.50 | 0.09 | 0.02 | 0.02 | -1.32 | -0.69 | -0.17 | -0.46 | -0.30 | -0.22 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 456.06M | 461.15M | 461.15M | 450.26M | 432.39M | 405.84M | 402.50M | 402.47M | 398.24M | 398.24M | 363.57M | 365.12M | 365.12M | 364.89M | 364.36M | 363.68M | 363.11M | 324.60M | 225.36M | 107.74M | 51.86M | 51.36M | 4.94M | 4.69M | 3.08M | 2.80M | 1.92M | 1.20M | 871.02K | 874.91K | 848.14K | 846.98K | 422.50M | 422.50M | 422.50M |
| Weighted Avg Shares Out (Dil) | 456.06M | 461.15M | 461.15M | 452.24M | 432.39M | 408.91M | 402.50M | 402.47M | 402.33M | 398.24M | 363.57M | 365.12M | 365.12M | 364.89M | 364.36M | 363.68M | 363.11M | 324.60M | 225.36M | 107.74M | 51.86M | 51.36M | 4.94M | 4.69M | 3.08M | 2.80M | 1.92M | 1.20M | 871.02K | 874.91K | 848.14K | 846.98K | 422.50M | 422.50M | 422.50M |
Source: https://incomestatements.info
Category: Stock Reports